Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:


Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 6,056,957

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,056,957
Title: Humanized monoclonal antibodies against human interleukin-5
Abstract:A monoclonal antibody is provided which specifically binds to human interleukin-5. Also provided are a hybridoma which produces the monoclonal antibody; complementary DNAs which encode the heavy and light chain variable regions of the monoclonal antibody and CDRs therefrom; humanized monoclonal antibodies; and pharmaceutical compositions comprising the monoclonal antibody or anti-idiotypic antibodies directed against it, humanized monoclonal antibodies, binding fragments, binding compositions or single-chain binding proteins derived from the antibody and a physiologically acceptable carrier.
Inventor(s): Chou; Chuan-Chu (Westfield, NJ), Murgolo; Nicholas J. (Millington, NJ), Abrams; John S. (Belmont, CA), Jenh; Chung-Her (Edison, NJ), Petro; Mary E. (Green Pond, NJ), Silver; Jon E. (San Jose, CA), Tindall; Stephen (Madison, NJ), Windsor; William T. (East Brunswick, NJ), Zavodny; Paul J. (Mountainside, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/284,516
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,056,957
Patent Claims:see list of patent claims

Details for Patent 6,056,957

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Teva Respiratory Llc CINQAIR reslizumab INJECTABLE;INJECTION 761033 001 2016-03-23   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2017-05-02 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.